0000899243-20-008471.txt : 20200316 0000899243-20-008471.hdr.sgml : 20200316 20200316170330 ACCESSION NUMBER: 0000899243-20-008471 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200316 FILED AS OF DATE: 20200316 DATE AS OF CHANGE: 20200316 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Alexandria Venture Investments, LLC CENTRAL INDEX KEY: 0001722024 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39247 FILM NUMBER: 20718015 BUSINESS ADDRESS: STREET 1: 26 NORTH EUCLID AVENUE CITY: PASADENA STATE: CA ZIP: 91101 BUSINESS PHONE: 626-578-0777 MAIL ADDRESS: STREET 1: 26 NORTH EUCLID AVENUE CITY: PASADENA STATE: CA ZIP: 91101 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IMARA Inc. CENTRAL INDEX KEY: 0001672619 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 811523849 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-206-2020 MAIL ADDRESS: STREET 1: 116 HUNTINGTON AVENUE STREET 2: 6TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-03-16 1 0001672619 IMARA Inc. IMRA 0001722024 Alexandria Venture Investments, LLC 26 NORTH EUCLID AVENUE PASADENA CA 91101 0 0 1 0 Common Stock 2020-03-16 4 C 0 293013 A 293013 D Series Seed Preferred Stock 2020-03-16 4 C 0 125432 0.00 D Common Stock 19913 0 D Series A Preferred Stock 2020-03-16 4 C 0 1433240 0.00 D Common Stock 227532 0 D Series B Preferred Stock 2020-03-16 4 C 0 287037 0.00 D Common Stock 45568 0 D On March 16, 2020, the Series Seed Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series Seed Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. On March 16, 2020, the Series A Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. On March 16, 2020, the Series B Preferred Stock converted into Common Stock on a 6.299-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date. /s/ Michael P. Gray, Attorney-in-Fact 2020-03-16